(Q44633880)

4 December 2017

title

The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma (English)

1 reference

4 December 2017

5

1 reference

4 December 2017

A Newbold

1

1 reference

4 December 2017

J M Salmon

series ordinal

2

1 reference

4 December 2017

B P Martin

series ordinal

3

1 reference

4 December 2017

K Stanley

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

2 December 2013

1 reference

4 December 2017

1 reference

4 December 2017

volume

33

1 reference

4 December 2017

issue

47

1 reference

4 December 2017

page(s)

5415-5423

1 reference

Anticancer activities of histone deacetylase inhibitors

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Histone deacetylase inhibitors: signalling towards p21cip1/waf1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

p21 in cancer: intricate networks and multiple activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

p15INK4b in HDAC inhibitor‐induced growth arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

p21waf1/Cip1 partially mediates apoptosis in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

Molecular and biologic analysis of histone deacetylase inhibitors with diverse specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.482

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.482

1 reference

4 December 2017

1 reference